Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas.

Saved in:
Bibliographic Details
Title: Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas.
Authors: Saenz-Ponce N; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland 4102, Australia., Pillay R; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland 4102, Australia., de Long LM; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland 4102, Australia., Kashyap T; Karyopharm Therapeutics Inc., Newton, MA 02459, USA., Argueta C; Karyopharm Therapeutics Inc., Newton, MA 02459, USA., Landesman Y; Karyopharm Therapeutics Inc., Newton, MA 02459, USA., Hazar-Rethinam M; Massachusetts General Hospital Cancer Center, Harvard Medical School, MA 02114, USA., Boros S; Department of Pathology, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia., Panizza B; Department of Ear Nose and Throat, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia.; School of Medicine, University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia., Jacquemyn M; Katholieke Universiteit Leuven, Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Herestraat 49, 3000 Leuven, Belgium., Daelemans D; Katholieke Universiteit Leuven, Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Herestraat 49, 3000 Leuven, Belgium., Gannon OM; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland 4102, Australia., Saunders NA; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland 4102, Australia. nsaunders@uq.edu.au.
Source: Science translational medicine [Sci Transl Med] 2018 Jun 27; Vol. 10 (447).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29950445
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Saenz-Ponce+N%22">Saenz-Ponce N</searchLink>; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland 4102, Australia.<br /><searchLink fieldCode="AU" term="%22Pillay+R%22">Pillay R</searchLink>; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland 4102, Australia.<br /><searchLink fieldCode="AU" term="%22de+Long+LM%22">de Long LM</searchLink>; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland 4102, Australia.<br /><searchLink fieldCode="AU" term="%22Kashyap+T%22">Kashyap T</searchLink>; Karyopharm Therapeutics Inc., Newton, MA 02459, USA.<br /><searchLink fieldCode="AU" term="%22Argueta+C%22">Argueta C</searchLink>; Karyopharm Therapeutics Inc., Newton, MA 02459, USA.<br /><searchLink fieldCode="AU" term="%22Landesman+Y%22">Landesman Y</searchLink>; Karyopharm Therapeutics Inc., Newton, MA 02459, USA.<br /><searchLink fieldCode="AU" term="%22Hazar-Rethinam+M%22">Hazar-Rethinam M</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, MA 02114, USA.<br /><searchLink fieldCode="AU" term="%22Boros+S%22">Boros S</searchLink>; Department of Pathology, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia.<br /><searchLink fieldCode="AU" term="%22Panizza+B%22">Panizza B</searchLink>; Department of Ear Nose and Throat, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia.; School of Medicine, University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia.<br /><searchLink fieldCode="AU" term="%22Jacquemyn+M%22">Jacquemyn M</searchLink>; Katholieke Universiteit Leuven, Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Herestraat 49, 3000 Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Daelemans+D%22">Daelemans D</searchLink>; Katholieke Universiteit Leuven, Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Herestraat 49, 3000 Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Gannon+OM%22">Gannon OM</searchLink>; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland 4102, Australia.<br /><searchLink fieldCode="AU" term="%22Saunders+NA%22">Saunders NA</searchLink>; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland 4102, Australia. nsaunders@uq.edu.au.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101505086%22">Science translational medicine</searchLink> [Sci Transl Med] 2018 Jun 27; Vol. 10 (447).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101505086 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1946-6242 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219466234%22">19466234 </searchLink><i>NLM ISO Abbreviation: </i>Sci Transl Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29950445
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1126/scitranslmed.aar7223
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Saenz-Ponce N
      – PersonEntity:
          Name:
            NameFull: Pillay R
      – PersonEntity:
          Name:
            NameFull: de Long LM
      – PersonEntity:
          Name:
            NameFull: Kashyap T
      – PersonEntity:
          Name:
            NameFull: Argueta C
      – PersonEntity:
          Name:
            NameFull: Landesman Y
      – PersonEntity:
          Name:
            NameFull: Hazar-Rethinam M
      – PersonEntity:
          Name:
            NameFull: Boros S
      – PersonEntity:
          Name:
            NameFull: Panizza B
      – PersonEntity:
          Name:
            NameFull: Jacquemyn M
      – PersonEntity:
          Name:
            NameFull: Daelemans D
      – PersonEntity:
          Name:
            NameFull: Gannon OM
      – PersonEntity:
          Name:
            NameFull: Saunders NA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 06
              Text: 2018 Jun 27
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1946-6242
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 447
          Titles:
            – TitleFull: Science translational medicine
              Type: main
ResultId 1